To evaluate our findings on NEDD9-driven MIN/DCIS increase in the human model, we overexpressed NEDD9 in human mammary epithelial cells—MCF10A—alone, or in combination with HER2 or empty vector controls (Figure 7A). The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.